Quick Answer
INTERPACE BIOSCIENCES, INC. reported Earnings Per Share Diluted of $0.89 per share for the year ending 2025.
- INTERPACE BIOSCIENCES, INC. showed an increase of +122.5% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from INTERPACE BIOSCIENCES, INC.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2010: $0.06 (loss) per share | Q3 2010: $0.11 (loss) per share | Q2 2011: $0.06 (loss) per share | Q3 2011: $0.01 (loss) per share | Q1 2012: $0.02 (loss) per share | Q2 2012: $0.03 (loss) per share | Q1 2013: $0.14 per share | Q2 2013: $0.06 (loss) per share | Q3 2013: $0.15 (loss) per share | Q1 2014: $0.11 (loss) per share | Q2 2014: $0.18 (loss) per share | Q3 2014: $0.29 (loss) per share | Q1 2016: $2.69 (loss) per share | Q2 2016: $1.29 (loss) per share | Q1 2017: $0.55 per share | Q2 2017: $0.65 (loss) per share | Q3 2017: $0.15 (loss) per share | Q1 2018: $0.11 (loss) per share | Q2 2018: $0.07 (loss) per share | Q3 2018: $0.11 (loss) per share | Q1 2022: $0.53 (loss) per share | Q2 2022: $0.93 (loss) per share | Q3 2022: $3.35 (loss) per share | Q1 2023: $0.12 per share | Q2 2023: $0.13 per share | Q3 2023: $0.04 (loss) per share | Q1 2024: $0.16 per share | Q2 2024: $0.55 per share | Q3 2024: $0.38 per share | Q1 2025: $0.06 per share | Q2 2025: $0.14 (loss) per share | Q3 2025: $0.03 per share.
- Over the full 4 years of available data (2022 to 2025), INTERPACE BIOSCIENCES, INC.'s Earnings Per Share Diluted has grown by 117.2%.
- Historical annual values: Fiscal year 2025: $0.89 per share | Fiscal year 2024: $0.40 per share | Fiscal year 2023: $0.45 per share | Fiscal year 2022: $5.18 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: